Hundreds of women with aggressive cervical cancer are to be offered a new immunotherapy on the NHS, which could help more women survive and stay cancer-free in the long-term.
Pembrolizumab – which experts describe as being able to ‘take the handbrake off the body’s immune system’ to target cancer – will now offer a new option for women in England with locally-advanced cervical cancer.
Read more – NHSE (25/6/26)